Dienogest
-
Post Date:
Dec 07,2018
-
Expiry Date:
Dec 07,2019
-
Detailed Description:
Cas No. :65928-58-7
Endometriosis is a chronic disease primarily affecting women of childbearing age, in which endometriotic lesions form outside the uterus, typically leading to painful symptoms, fatigue, and infertility. The symptoms of endometriosis may cause significant impairment in quality of life and represent a substantial economic burden to patients, families, and society. There is no cure for endometriosis; management consists of alleviating pain and other symptoms, reducing endometriotic lesions, and improving quality of life. Recurrence after surgical intervention is common, while the clinical evidence to support the efficacy and safety of many medications currently used in endometriosis is limited. Dienogest is an oral progestin that has been investigated extensively in the treatment of endometriosis in two clinical programs performed in Europe and Japan, including dose-ranging, placebo-controlled, active comparator-controlled, and long-term (up to 65 weeks) studies.
-
CAS Registry Number:
65928-58-7
-
Synonyms:
;Dienogest;(17a)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile;17a-Cyanomethyl-17-hydroxyestra-4, 9-dien-3-one;Dienogestril;Endometrion;STS 557;[(17beta)-17-hydroxy-3-oxoestra-4,9-dien-17-yl]acetonitrile;
-
Molecular Formula:
C20H25NO2
-
Molecular Weight:
311.418
-
Molecular Structure:
-
Company:
Jinan Chenghishaungda Chemical Co.,LTD
[ China ]
-
Contact:
Allen
-
Tel:
15689693073
-
Fax:
0531-58897032
-
Email:
3118607598@qq.com
Inquiry